Efficacy of Unani Hair Oil in Inteshar Al-Sha’r (Diffuse Hair Loss) – A Randomised Single Blind Placebo Controlled Clinical Trial - NI

Government Unani Medical College and Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年12月19日

试验速览

暂无简介。

•Clinically diagnosed patients of DHL.
•Female patients of 18-50 years age.
•Patients with Hair Shedding Score greater than or equal to 5.
•Cases of DHL associated with stress of any kind such as postpartum, postoperative or post febrile, deficiency states such as iron deficiency and protein malnutrition.
•Patients who have agreed to sign the informed consent form and follow up during the protocol.

•Female patients less than 18 yrs of age and greater than 50 yrs.
•Patients suffering from other scalp diseases like scalp psoriasis, seborrhoeic dermatitis, tinea capitis, alopecia areata, scarring alopecia, congenital alopecia, alopecia totalis, alopecia universalis and trichotillomania.
•Patients on systemic drugs like anticoagulants, immunosuppressants, and antithyroid drugs.
•Pregnant, lactating or postmenopausal women.
•Known cases of hypothyroidism.
•Patients on chemotherapy and radiotherapy.
•History of any treatment for hair loss within previous one month.

发起方

Government Unani Medical College and Hospital